Blog
Things have changed for the better. Is that the case for your neurological condition?
Sarah Joiner, Vice Chair of the MS Trust and member of The Neurological Alliance #MyNeuroSurvey Steering Group, writes: I was diagnosed with multiple sclerosis in 1981. Back then I received care from a consultant and a small medical team. Hours of waiting all morning, an examination to see how the condition had progressed, and some […]
We have never needed patient advocacy and citizen advocacy more than we need it now
Caroline Clarke, CEO at the Royal Free London NHS Foundation Trust, writes: Thank you for giving me the opportunity to speak at your AGM and to restate what I said then to your members in this blog. I am the CEO at the Royal Free London NHS Foundation Trust, a group of hospitals in North […]
Celebrating achievements across the neuro community
As we publish our annual report, we reflect on the Alliance’s activities in the last financial year (July 2020 – June 2021), celebrate achievements from across the neurological community, and look to the future.
Reasons to be a radiator
Georgina Carr, Chief Executive, outlines her hopes for the new year: Like many of us, I’ve found this year to be incredibly difficult. The impacts of the Covid-19 pandemic seem to be relentless. People, communities and services are incredibly resilient, but have been tested as never before. At our AGM last week, our wonderful speaker, […]
Alliance urges NHS England and NHS Improvement to appoint a national clinical director for neurology
The Neurological Alliance has written an urgent letter – backed by over 30 groups supporting people with neurological conditions – to the NHS England and NHS Improvement Medical Director, Professor Steven Powis, calling for the appointment of a National Clinical Director (NCD) for neurology. The call comes as the NHS in England is undergoing substantial […]
Government announces £375 million investment in neurodegenerative conditions research
On Sunday (14th November) the government announced £375 million of investment over the next five years to fund projects to improve our understanding and treatment of a range of neurodegenerative conditions, including Motor Neurone Disease (MND), Parkinson’s disease dementia and Lewy’s Body dementia. The announcement comes after the success of the United to End MND […]
